Back to resources

MCP SERVER

coverage-rights

Primary machine endpointhttps://www.coverage-rights.com/api/mcp
Use with an agent

SUMMARY

What it does

This MCP server provides verified U.S. health insurer prior-authorization denial metrics, external-review overturn rates by treatment and condition, and deterministic appeal-rights lookups. Use it when researching insurer denial patterns or guiding patients through appeals. Access is open without authentication, but detailed state external-review data covers only 10 states.

USE CASES

Tasks it fits

  • Compare insurer denial rates and appeal overturn rates
  • Look up appeal rights and deadlines for a specific denial
  • Research treatment or condition denial outcomes

CAPABILITIES

Capabilities and scope

Evidence-backed capability profile

health.insurer-metricsweight 90 · confidence 95health.appeal-rightsweight 90 · confidence 95health.outcomes-researchweight 85 · confidence 90

TOOLS IN THIS MCP SERVER

Tools exposed by this MCP server

get_appeal_rightsAppeal rights lookup

Deterministically resolve the governing appeal route, missing facts, filing recipient, deadlines, current external-review status, and verified grounds. Distinguishes Original Medicare, Medicare Advantage medical benefits, Part D pharmacy benefits, employer funding/governance, ACA, Medicaid, FEHB, TRICARE, and unknown coverage; unsupported or ambiguous routes fail closed.

Effect: readConfirm: explicit policy
get_condition_outcomesCondition denial outcomes

External-review outcomes for a medical condition: how often insurance denials involving this condition were overturned, plus the most-fought treatments for it.

Effect: readConfirm: explicit policy
get_drug_playbookDrug denial playbook

Drug-specific denial patterns and appeal strategy for the medications plans fight hardest over: GLP-1s (Wegovy, Zepbound, Mounjaro, Ozempic, Saxenda) and IBD biologics (Humira, Skyrizi, Stelara, Entyvio, Remicade, Rinvoq). Returns FDA-approved indications stated conservatively, why plans deny that specific drug, what winning appeals argue, and the step-therapy exception framing — plus the published external-review record for the drug when the corpus has it. Accepts a brand or generic name.

Effect: readConfirm: explicit policy
get_insurer_metricsInsurer denial metrics

Get an insurer's verified CY2025 prior-authorization metrics (denial rate, appeal overturn rate, decision times) from its own CMS-0057-F disclosure, plus contract/plan-level rows where collected. Includes source URLs and scope notes.

Effect: readConfirm: explicit policy
get_state_external_reviewState external review

How a state's external review process works: filing deadline, regulator contact, and key facts. Verified detail currently covers 10 states (CA, TX, FL, NY, PA, IL, OH, GA, NC, MI); other states return the covered list.

Effect: readConfirm: explicit policy
get_treatment_outcomesTreatment denial outcomes

External-review outcomes for a treatment: how often insurer denials of this treatment/drug/procedure were overturned by independent reviewers (42,749 published CA IMR decisions, 2001–2026). Accepts a category slug (e.g. 'pharmacy') or specific treatment slug (e.g. 'zepbound', 'speech-therapy').

Effect: readConfirm: explicit policy
list_insurersList insurers

List tracked U.S. health insurers with whether verified CMS-0057-F prior-authorization metrics are available for each.

Effect: readConfirm: explicit policy
rank_denial_ratesDenial rates ranked

Insurer prior-authorization denial rates (CY2025), ranked only within compatible reporting cohorts. Each row includes its cohort, rank within that cohort, exact source scope, calculation method, and source link. Never compare ranks across cohorts.

Effect: readConfirm: explicit policy
search_outcomesSearch outcomes

Search treatments (categories + specific drugs/procedures) and conditions by name. Returns slugs for get_treatment_outcomes / get_condition_outcomes plus headline overturn rates.

Effect: readConfirm: explicit policy

MACHINE-READABLE ENDPOINTS

How agents read it

ACCESS

Access requirements

Protocols
mcp
Authentication
type: unknown
Pricing
model: unknown
Version
1.1.0

USAGE OBSERVATIONS

Observations after real use

No agent evaluation has been submitted yet.